Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes.
(1999) Acta Clinica Belgica (Multilingual Edition) — Vol. 54, n° 6, p. 328-333 (1999)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- The aim of the study was to evaluate the current antihyperglycaemic and antihypertensive treatment schemes as well as the quality of metabolic control and blood pressure in a population with type 2 diabetes, in view of the United Kingdom Prospective Diabetes Study (UKPDS) data. 318 patients were included. 44% were treated with metformin and/or sulfonylurea. 44% received insulin in monotherapy or combined with oral drugs. HbA1c was 8.0 (7.9-9.4)% (median; percentiles 25-75). Chronic neurological and vascular (micro- and macroangiopathy) complications were present in 21-43% of patients and were related to glycaemic control. (Un)treated hypertension was found in 59% of patients. Main treatments were ACE-inhibitors (40%), calcium channel antagonists and diuretics (20%) and/or beta-blockers (18%). Systolic and diastolic blood pressure were 147 +/- 22 and 86 +/- 12 mm/Hg (mean +/- 1 SD). In conclusion, overall glycaemic control of a type 2 diabetic population remains slightly unsatisfactory in view of the UKPDS recommendations. In contrast, blood pressure control was adequate.
- Affiliations
Citations
Buysschaert, M., & Hermans, M. (1999). Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes. Acta Clinica Belgica (Multilingual Edition), 54(6), 328-333. https://hdl.handle.net/2078.5/55460 (Original work published 1999)